News

One-time Amtagvi Treatment Demonstrated Durable Responses and a Five-year Overall Survival Rate of 20%. Five-year Follow Up is Unprecedented for Any Therapy in Patients with Advan ...
Clear signs of immune activation: ICT01 at the 10 mg dose provided optimal activation of γ9δ2 T cells and a downstream immune ...
No needles, no downtime, no transplants. TED by Alma is the ultrasound-powered, noninvasive hair restoration treatment ...
ILC accounts for 10–15% of breast cancers and often goes undetected. Learn about its characteristics, treatments, and future ...
Realizing their options for medically assisted death are so far limited in New York, a Catskills couple decided to seek it in Oregon.
Critically ill patients in ICU now have the option of staying awake while on life support. Read more at straitstimes.com.
The FDA is likely to approve the first treatment for smoldering multiple myeloma but pass on a new option relapsed/refractory DLBCL, after votes by its Oncologic Drugs Advisory Committee.
Margrit Wiesendanger, MD, PhD, discusses how lupus treatment is evolving from traditional therapies to more targeted options like biologics, with promising advances now being explored in clinical ...
The Gout Education Society announces the launch of "Crystal Clear"?a campaign underscoring the importance of clarity for both patients and medical professionals related to gout diagnosis, treatment ...
Learn the signs of pancreatic cancer including unexplained weight loss, distinctive pain patterns, digestive changes, and ...
NICE is also looking at the role of Hympavzi in treating severe haemophilia A, where there are other subcutaneous options ...
Folliculitis is a common skin condition that occurs when hair follicles become inflamed due to infection, irritation, or ...